# ADZENYS ER
> **NDA204325** · New Drug Application · Sponsor: NEOS THERAPS INC · Approved 2017-09-15
## Drug
- **FDA Application Number:** NDA204325
- **Application type:** New Drug Application
- **Brand name:** ADZENYS ER
- **Generic name:** Amphetamine
- **Active ingredients:** AMPHETAMINE
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NEOS THERAPS INC
- **First approval:** 2017-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204325)
---
*AI Analytics · CC0 1.0*